These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19279002

  • 21. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.
    Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA.
    Mol Cell Biol; 2004 Oct; 24(19):8477-86. PubMed ID: 15367669
    [Abstract] [Full Text] [Related]

  • 22. Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells.
    Baird L, Dinkova-Kostova AT.
    Biochem Biophys Res Commun; 2013 Mar 29; 433(1):58-65. PubMed ID: 23454126
    [Abstract] [Full Text] [Related]

  • 23. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R, Shah P, Guha R, Rassool FV, Tomkinson AE, Brodie A, Jaiswal AK.
    Mol Cancer Ther; 2015 Jul 29; 14(7):1728-37. PubMed ID: 25976679
    [Abstract] [Full Text] [Related]

  • 24. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM, Kruszewski MK.
    Free Radic Biol Med; 2011 May 01; 50(9):1186-95. PubMed ID: 21295136
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
    Martinez VD, Vucic EA, Pikor LA, Thu KL, Hubaux R, Lam WL.
    Mol Cancer; 2013 Oct 20; 12(1):124. PubMed ID: 24138990
    [Abstract] [Full Text] [Related]

  • 27. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
    Sekhar KR, Rachakonda G, Freeman ML.
    Toxicol Appl Pharmacol; 2010 Apr 01; 244(1):21-6. PubMed ID: 19560482
    [Abstract] [Full Text] [Related]

  • 28. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.
    Furukawa M, Xiong Y.
    Mol Cell Biol; 2005 Jan 01; 25(1):162-71. PubMed ID: 15601839
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.
    Ichikawa T, Li J, Meyer CJ, Janicki JS, Hannink M, Cui T.
    PLoS One; 2009 Dec 21; 4(12):e8391. PubMed ID: 20027226
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nuclear import and export signals in control of Nrf2.
    Jain AK, Bloom DA, Jaiswal AK.
    J Biol Chem; 2005 Aug 12; 280(32):29158-68. PubMed ID: 15901726
    [Abstract] [Full Text] [Related]

  • 33. Fuzzy complex formation between the intrinsically disordered prothymosin α and the Kelch domain of Keap1 involved in the oxidative stress response.
    Khan H, Cino EA, Brickenden A, Fan J, Yang D, Choy WY.
    J Mol Biol; 2013 Mar 25; 425(6):1011-27. PubMed ID: 23318954
    [Abstract] [Full Text] [Related]

  • 34. p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.
    Tao S, Liu P, Luo G, Rojo de la Vega M, Chen H, Wu T, Tillotson J, Chapman E, Zhang DD.
    Mol Cell Biol; 2017 Apr 15; 37(8):. PubMed ID: 28115426
    [Abstract] [Full Text] [Related]

  • 35. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
    Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M.
    Mol Cell Biol; 2004 Aug 15; 24(16):7130-9. PubMed ID: 15282312
    [Abstract] [Full Text] [Related]

  • 36. Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.
    Tsai YS, Jou YC, Tsai HT, Shiau AL, Wu CL, Tzai TS.
    Cancer Sci; 2019 Apr 15; 110(4):1208-1219. PubMed ID: 30719818
    [Abstract] [Full Text] [Related]

  • 37. Structural analysis of the complex of Keap1 with a prothymosin alpha peptide.
    Padmanabhan B, Nakamura Y, Yokoyama S.
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Apr 01; 64(Pt 4):233-8. PubMed ID: 18391415
    [Abstract] [Full Text] [Related]

  • 38. [Influence of prothymosin alpha and its mutants on activity of the p53 tumor suppressor].
    Zakharova NI, Sokolov VV, Rud'ko VV, Mel'nikov SV, Vartapetian AB, Evstaf'eva AG.
    Mol Biol (Mosk); 2008 Apr 01; 42(4):673-84. PubMed ID: 18856068
    [Abstract] [Full Text] [Related]

  • 39. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex.
    McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD.
    J Biol Chem; 2006 Aug 25; 281(34):24756-68. PubMed ID: 16790436
    [Abstract] [Full Text] [Related]

  • 40. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT.
    Antioxid Redox Signal; 2010 Dec 01; 13(11):1713-48. PubMed ID: 20446772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.